Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Using music to reduce stress during botulinum toxin injections for spasticity

Official title: Interest of a Musical Intervention on Stress Induced During Botulinum Toxin Injections in Spasticity

Run by University Hospital, Clermont-Ferrand · NCT06920524 · Data updated 2026-11-12

This study tests if listening to music during botulinum toxin injections can help adults with spasticity feel less pain and anxiety.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment80 (estimated)
SponsorUniversity Hospital, Clermont-Ferrand
Academic / other
Locations1 site (Clermont-Ferrand)
StatusRecruiting
StartedApril 25, 2025
Main results expectedOctober 30, 2027
Study endsOctober 30, 2027
Registry record updatedMay 23, 2025
Trial IDNCT06920524 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults with spasticity of neurological origin who are eligible for botulinum toxin injections and experience pain or anxiety.

Probably not a fit

Patients with severe hearing impairments, major cognitive impairments, or those requiring sedation during injections may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the impact of a musical intervention on patients undergoing botulinum toxin injections for spasticity caused by neurological conditions such as stroke and multiple sclerosis. The intervention aims to alleviate pain and anxiety associated with the injections by employing a structured music therapy approach. Participants will be exposed to music during their injection sessions to assess its effectiveness in improving their overall experience and tolerance of the procedure. The study focuses on adult patients who are eligible for botulinum toxin treatments and have reported pain or anxiety.

Why it matters

Potential benefit: If successful, this intervention could significantly enhance the comfort and emotional well-being of patients receiving botulinum toxin injections.

How similar studies have gone: Previous studies have shown that music therapy can effectively reduce pain and anxiety in various medical contexts, suggesting potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult patients, male or female, suffering from spasticity of neurological origin (multiple sclerosis, stroke, head trauma, etc.) and eligible for botulinum toxin injection treatments.
* Patients with known pain and/or anxiety
* Able to give informed consent to participate in research
* Enrolled in a French Social Security system

Exclusion Criteria:

* Contraindication to musical intervention (severe hearing impairment, unstabilized psychotic disorders, history of auditory trauma)
* Major cognitive impairment
* Any medical condition deemed by the investigator to be incompatible with the research.
* Indication for MEOPA sedation during botulinum toxin injection sessions
* Medication or medical conditions likely to interfere with heart rate variability during the study: beta-blockers, anti-arrhythmics, anxiolytics, benzodiazepines, anti-hypertensives and calcium antagonists.
* Pregnant or breast-feeding women
* Refusal to participate

Where it's running

  • CHU de Clermont-Ferrand
    Clermont-Ferrand, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.